UK markets open in 1 hour 35 minutes
  • NIKKEI 225

    29,378.32
    +46.95 (+0.16%)
     
  • HANG SENG

    28,703.37
    +65.91 (+0.23%)
     
  • CRUDE OIL

    65.10
    +0.39 (+0.60%)
     
  • GOLD FUTURES

    1,820.80
    +5.10 (+0.28%)
     
  • DOW

    34,548.53
    +318.19 (+0.93%)
     
  • BTC-GBP

    40,222.98
    -1,005.03 (-2.44%)
     
  • CMC Crypto 200

    1,449.28
    -22.14 (-1.50%)
     
  • ^IXIC

    13,632.84
    +50.42 (+0.37%)
     
  • ^FTAS

    4,032.10
    +20.59 (+0.51%)
     

Analysts optimistic on Sensyne Health outlook

Michael Green
·1-min read

The Sensyne Health (LON:SENS) share price has risen by 125.4% over the past month and it’s currently trading at 66.5. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, Sensyne Health currently has:

  • 2 Buy recommendations

  • 0 Hold recommendations

  • 0 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:SENS »

Researching beyond broker forecasts

At its current price of 66.5, shares in Sensyne Health are trading at a discount of -55.8% to its 52 week high price. The 1-year performance of the shares has been -55.1%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of Sensyne Health it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Sensyne Health that you can find out about here.

Alternatively, if you'd like to find more shares that analysts are bullish about, you can find them on this Positive Momentum & Broker Buys screen.